NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 127 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,370 | -18.7% | 1,071 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $5,376 | +79.2% | 1,071 | +665.0% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 140 | +2.2% | 0.00% | -100.0% |
| Q3 2020 | $2,000 | -33.3% | 137 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $3,000 | +50.0% | 137 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | 0.0% | 137 | +16.1% | 0.00% | 0.0% |
| Q4 2019 | $2,000 | – | 118 | +321.4% | 0.00% | – |
| Q3 2019 | $0 | – | 28 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $237,228,000 | 52.50% |
| Ponoi II Management, LLC | 1,298,908 | $16,990,000 | 44.41% |
| Ponoi Management, LLC | 1,298,908 | $16,990,000 | 23.20% |
| Euclidean Capital LLC | 746,674 | $9,766,000 | 9.07% |
| StepStone Group LP | 1,573,357 | $20,580,000 | 2.93% |
| Logos Global Management LP | 850,000 | $11,118,000 | 1.37% |
| First Light Asset Management, LLC | 955,505 | $12,498,000 | 1.26% |
| GREAT POINT PARTNERS LLC | 316,256 | $4,137,000 | 1.00% |
| Rubric Capital Management LP | 877,161 | $11,473,000 | 0.58% |
| Avidity Partners Management LP | 1,798,100 | $23,519,000 | 0.48% |